HMB added to EPA/DHA supplementation increases postabsorptive net protein breakdown in COPD patients
In a 10-week RCT, COPD patients receiving HMB + EPA/DHA showed a significant increase in postabsorptive net protein breakdown (p=0.028), while EPA/DHA alone did not. Both interventions increased lean soft tissue, but only HMB + EPA/DHA reduced whole body and extremity fat mass.
Evidence Score
Study Evidence
Study 1. Functional and metabolic effects of omega-3 polyunsaturated fatty acid supplementation and the role of β-hydroxy-β-methylbutyrate addition in chronic obstructive pulmonary disease: A randomized clinical trial.
observationalEngelen MPKJ, Simbo SY, Ruebush LE, Thaden JJ, Ten Have GAM, Harrykissoon RI, Zachria AJ, Calder PC, Pereira SL, Deutz NEP ยท Clinical nutrition (Edinburgh, Scotland) (2024)
Result:
Mechanism Graph
Limitations
- โ Small sample size (n=46) limits generalizability
- โ Whether HMB alone or synergistic with EPA/DHA causes fat loss remains unclear
- โ No significant improvements in muscle function, brain health, or quality of life were observed
Frequently Asked Questions
What is the main finding of this study?โผ
Adding HMB to EPA/DHA supplementation for 10 weeks increased net protein breakdown and reduced fat mass in COPD patients, while EPA/DHA alone increased lean soft tissue but not fat loss.
How does HMB affect protein metabolism in COPD?โผ
HMB combined with EPA/DHA increased postabsorptive net protein breakdown, suggesting enhanced protein turnover cycling that may support muscle remodeling.
Did EPA/DHA alone improve muscle function in COPD patients?โผ
No, EPA/DHA supplementation increased lean soft tissue but did not improve muscle function, brain health, or quality of life in this study.
What were the anti-inflammatory effects of HMB + EPA/DHA?โผ
The HMB + EPA/DHA group showed reductions in several proinflammatory cytokines including IL-2, IL-17, IL-6, IL-12P40, and TNF-ฮฒ.
Products
Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.
References
- 1.Engelen MPKJ, Simbo SY, Ruebush LE, Thaden JJ, Ten Have GAM, Harrykissoon RI, Zachria AJ, Calder PC, Pereira SL, Deutz NEP. "Functional and metabolic effects of omega-3 polyunsaturated fatty acid supplementation and the role of β-hydroxy-β-methylbutyrate addition in chronic obstructive pulmonary disease: A randomized clinical trial.." Clinical nutrition (Edinburgh, Scotland), 2024. PMID: 39181037 DOI: 10.1016/j.clnu.2024.08.004